The expansion of the company’s third facility in San Diego will make it 38,000 sqft and will be equipped for cold chain requirements
PCI Pharma Services has made an expansion to its third facility in San Diego that will grow its West Coast Clinical operations.
The San Diego site is one of the biopharmaceutical outsourcing services provider’s eight global clinical locations across the US, EU and the Asia Pacific regions supporting clinical trials.
PCI’s new two-story 38,000 sqft facility – located less than a mile from its existing San Diego campus – will serve as PCI’s main storage, logistics and distribution centre on the West Coast. Beyond controlled room temperature, the building will be equipped for cold chain requirements for 2-8°C, -20°C, and -80°C with expanded ultra-low freezer capabilities, as well as cryogenic liquid nitrogen storage at -196°C.
The site expansion project will be completed and validated during the fourth quarter of 2019.
PCI’s Mark Shepanski, Executive Director of Operations and Site Lead for San Diego, said: “Securing our third site in San Diego allows us to continue to provide industry-leading reliability, flexibility and quality in clinical supply management services.
“We began to investigate our requirements for the additional facility last year, anticipating our customers would eventually need additional storage space for their larger Clinical studies,” Shepanski added. “As our customers experience continued success, we want to make sure we adapt and grow with them.”
This announcement is the latest reflecting PCI’s commitment to the continued development and expansion of its global clinical supply network in anticipation of future customer needs; a strategy which includes ongoing and considerable capital investment in facilities and increased capacity.
Management team updates have also been implemented to help drive the company’s future vision, strategy and growth. The senior positions include newly created and expanded roles in Strategic Marketing, Program Management, Clinical Services and Global Clinical Quality.
Commenting on the changes, PCI CEO, Salim Haffar, said: “The strategic direction PCI is taking will help us and our clients prepare for the future. We are investing in global infrastructure, innovation, and our leadership to ensure enhanced focus on delivering the best customer experience and solidifying our well-recognised position within the industry. I’m inspired by the strength of our internal management team, and our ability to elevate and leverage their talent to launch these new functions and initiatives.”